Literature DB >> 20146588

Oral cancer screening: what have we learnt and what is there still to achieve?

Paul R Brocklehurst1, Sarah R Baker, Paul M Speight.   

Abstract

Oral cancer is an important global healthcare problem. In the UK, the incidence is increasing and late-stage presentation is common. Determining the feasibility of a national screening program for oral cancer is therefore an important step in the prevention of the disease. Evidence exists to suggest that an oral examination of high-risk individuals may be a cost-effective screening strategy. However, questions remain over which primary care environment would be the most suitable and the criteria for a positive screen and referral. Further research is needed in the form of clinical trials or demonstration studies in primary care. The impact on secondary care, the role of auxiliaries and training needs also need to be determined. In addition, the assessment of adjunctive aids and evaluation of potential biomarkers are considered important.

Entities:  

Mesh:

Year:  2010        PMID: 20146588     DOI: 10.2217/fon.09.163

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  25 in total

1.  Immunophenotyping of HPV Types 16 and 18 among Sudanese Patients with Oral Lesions.

Authors:  Ibrahim A M Ginawi; Ebtihag A Mahgoub; Hussain G Ahmed
Journal:  Oman Med J       Date:  2012-05

2.  [Differential expression profiles of microRNAs/mRNA and docking study in oral squamous cell carcinoma].

Authors:  Siyu Liu; Long Xie; Bing Qi; Changyan Ma; Lei Sang; Hongwei Li
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2014-08

Review 3.  Screening programmes for the early detection and prevention of oral cancer.

Authors:  Paul Brocklehurst; Omar Kujan; Lucy A O'Malley; Graham Ogden; Simon Shepherd; Anne-Marie Glenny
Journal:  Cochrane Database Syst Rev       Date:  2013-11-19

Review 4.  Current Status, Opportunities, and Challenges of Exosomes in Oral Cancer Diagnosis and Treatment.

Authors:  Hongyu Liu; Yisheng Huang; Mingshu Huang; Zhijie Huang; Qin Wang; Ling Qing; Li Li; Shuaimei Xu; Bo Jia
Journal:  Int J Nanomedicine       Date:  2022-06-16

5.  TRAF4 enhances oral squamous cell carcinoma cell growth, invasion and migration by Wnt-β-catenin signaling pathway.

Authors:  Jianbin Yang; Dongyi Wei; Weixin Wang; Baohong Shen; Suling Xu; Yuan Cao
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 6.  Clinical assessment to screen for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults.

Authors:  Tanya Walsh; Joseph L Y Liu; Paul Brocklehurst; Anne-Marie Glenny; Mark Lingen; Alexander R Kerr; Graham Ogden; Saman Warnakulasuriya; Crispian Scully
Journal:  Cochrane Database Syst Rev       Date:  2013-11-21

7.  Naa10p Enhances Chemosensitivity to Cisplatin in Oral Squamous Cell Carcinoma Cells.

Authors:  Lichun Sun; Kaixin Wang; Lu Peng; Jinfang Zhang; Jie Yang; Juan Zhao; Jiang Xu; Jun Zheng; Yan Zeng
Journal:  Cancer Manag Res       Date:  2021-02-22       Impact factor: 3.989

8.  Current training provision and training needs in oral health for UK general practice trainees: survey of General Practitioner Training Programme Directors.

Authors:  Aneeta Ahluwalia; Tim Crossman; Helen Smith
Journal:  BMC Med Educ       Date:  2016-05-11       Impact factor: 2.463

9.  Long non-coding RNA LINC01137 contributes to oral squamous cell carcinoma development and is negatively regulated by miR-22-3p.

Authors:  Yong Du; Haiyan Yang; Yue Li; Wenli Guo; Yufeng Zhang; Haitao Shen; Lingxiao Xing; Yuehong Li; Wenxin Wu; Xianghong Zhang
Journal:  Cell Oncol (Dordr)       Date:  2021-04-02       Impact factor: 6.730

10.  CircRNA HIPK3 promotes the progression of oral squamous cell carcinoma through upregulation of the NUPR1/PI3K/AKT pathway by sponging miR-637.

Authors:  Weipeng Jiang; Chunxiao Zhang; Xiaoming Zhang; Legang Sun; Jikui Li; Jinhua Zuo
Journal:  Ann Transl Med       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.